Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 271–300 of 574 companies · sorted by market cap (high to low)
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| ARDT | ARDENT HEALTH INC | Health Care | $10.37 | $1.5B | 11.0 | +6.7% | +2.1% | n/a | -1.3% |
| INSP | Inspire Medical Systems | Health Care | $50.40 | $1.5B | 11.1 | +8.9% | +14.3% | n/a | -61.1% |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Health Care | $18.82 | $1.5B | n/a | +1.2% | -30.1% | n/a | +56.2% |
| AVBP | ARRIVENT BIOPHARMA INC | Health Care | $30.44 | $1.4B | n/a | n/a | n/a | n/a | +41.2% |
| AHCO | ADAPTHEALTH CORP | Health Care | $10.88 | $1.4B | n/a | +1.2% | -2.4% | n/a | +14.8% |
| XNCR | XENCOR INC | Health Care | $19.51 | $1.4B | n/a | -25.4% | -177.1% | n/a | +112.1% |
| ABSI | ABSCI CORP | Health Care | $8.24 | $1.4B | n/a | -61.9% | -6450.8% | n/a | +127.0% |
| PNTG | PENNANT GROUP INC | Health Care | $40.45 | $1.4B | 45.7 | +36.8% | +3.0% | n/a | +71.2% |
| PAHC | PHIBRO ANIMAL HEALTH CORP CLASS A | Health Care | $33.81 | $1.4B | 14.4 | +26.0% | +6.3% | +1.4% | +14.3% |
| AKTS | AKTIS ONCOLOGY INC | Health Care | $24.81 | $1.4B | n/a | +49.9% | -843.9% | n/a | -82.5% |
| PRGO | Perrigo | Health Care | $10.47 | $1.4B | n/a | -3.6% | -43.5% | +11.1% | -64.1% |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | Health Care | $38.17 | $1.3B | n/a | n/a | n/a | n/a | +98.1% |
| PURR | HYPERLIQUID STRATEGIES INC | Health Care | $6.85 | $1.3B | n/a | n/a | n/a | n/a | +82.9% |
| AMN | AMN HEALTHCARE INC | Health Care | $34.19 | $1.3B | n/a | +19.9% | -0.9% | n/a | +71.6% |
| NVAX | NOVAVAX INC | Health Care | $7.91 | $1.3B | 2.9 | -52.5% | -14.7% | n/a | -0.2% |
| AZTA | AZENTA INC | Health Care | $27.16 | $1.3B | n/a | -5.9% | -29.9% | n/a | -17.9% |
| AVLN | AVALYN PHARMA INC | Health Care | $28.72 | $1.3B | n/a | n/a | n/a | n/a | -2.6% |
| PSNL | PERSONALIS INC | Health Care | $12.47 | $1.3B | n/a | -24.7% | -148.1% | n/a | +80.8% |
| OMDA | OMADA HEALTH INC | Health Care | $21.84 | $1.3B | n/a | +42.0% | -2.2% | n/a | +10.1% |
| INBX | INHIBRX BIOSCIENCES INC | Health Care | $85.92 | $1.3B | n/a | +550.0% | -5465.6% | n/a | +275.9% |
| FBRX | FORTE BIOSCIENCES INC | Health Care | $56.63 | $1.3B | n/a | -99.8% | -158775.0% | n/a | +443.0% |
| ATEC | ALPHATEC HOLDNGS INC | Health Care | $8.06 | $1.3B | n/a | +22.6% | -15.9% | n/a | -25.0% |
| ARDX | ARDELYX INC | Health Care | $5.08 | $1.3B | n/a | +18.2% | -13.6% | n/a | +14.8% |
| CNMD | CONMED CORP | Health Care | $42.00 | $1.3B | 22.8 | +4.1% | +4.0% | +1.9% | -12.6% |
| KMTS | KESTRA MEDICAL TECHNOLOGIES LTD | Health Care | $20.89 | $1.2B | n/a | +59.1% | -173.0% | n/a | +22.7% |
| ETON | ETON PHARMACEUTCIALS INC | Health Care | $43.58 | $1.2B | n/a | +79.9% | -1.7% | n/a | +198.7% |
| STAA | STAAR SURGICAL | Health Care | $24.71 | $1.2B | n/a | +4.0% | -7.2% | n/a | +25.4% |
| JBIO | JADE BIOSCIENCES INC | Health Care | $19.85 | $1.2B | n/a | n/a | n/a | n/a | +121.0% |
| IRMD | IRADIMED CORP | Health Care | $94.08 | $1.2B | 50.9 | +14.8% | +27.4% | +0.9% | +67.1% |
| AORT | ARTIVION INC | Health Care | $25.14 | $1.2B | 102.7 | +17.6% | +2.5% | n/a | -17.3% |
This is a shareable URL: filters live in the query string — e.g.
/browse?sector=Health+Care, /browse?index=russell2000,
/browse?mktcap=small, /browse?pe_band=under15,
/browse?growth_band=over20, /browse?margin_band=over20,
/browse?div_yield_band=over4, /browse?div_streak=ge10,
/browse?insider=cluster-buy, /browse?holder=blackrock,
/browse?short=elevated.
Combine them, sort with &sort=dividend_yield&dir=desc (or click a column
header), and page with &page=2.
Data: SEC EDGAR (filings) + Finnhub (prices, fundamentals), as of 2026-07-24 close. Prices are delayed daily-close, labelled with their as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date. Past performance does not indicate future results.